Skip to content
ClinCalc Pro
Menu
Long-Acting Corticosteroid (Joint Injection)

Betamethasone Dipropionate

Brand names: Celestone Soluspan, Diprospan

Betamethasone dipropionate is a potent long-acting corticosteroid; in the orthopaedic context an injectable betamethasone ester preparation is used for intra-articular and soft-tissue injection to reduce inflammation in joints, bursae and tendon sheaths.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It binds glucocorticoid receptors to suppress the local inflammatory cascade, reducing cytokine production, leucocyte activity and prostaglandin synthesis at the injected site.

Prescribing in practice

  • Do not inject into a joint or soft tissue if local or systemic infection is suspected, as corticosteroid injection can worsen and mask sepsis; exclude septic arthritis first.
  • Use aseptic technique and limit the frequency of injections into a single joint, as repeated injections can damage cartilage and surrounding tissue.
  • Systemic absorption can transiently raise blood glucose and suppress the adrenal axis, and post-injection flare may occur.

Monitoring

Monitor the injected joint for response and signs of infection, and review glycaemic control in patients with diabetes after injection.

Counselling the patient

  • Some soreness may occur for a day or two after the injection before benefit is felt; rest the joint as advised.
  • Seek urgent review if the joint becomes hot, increasingly swollen, very painful or you develop a fever.

Evidence & guidelines

Intra-articular corticosteroid injection is an established option for inflammatory joint and soft-tissue conditions, supported by standard musculoskeletal practice guidance.

Reference: NICE CG177 (OA 2022); SPC Diprospan; Cochrane Review (IA steroids for OA knee); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.